Karolinska CCC Achieves Renewed Accreditation, Boosting Cancer Care and Research in Sweden
Karolinska CCC becomes the first in Sweden to secure renewed accreditation, enhancing cancer care and research integration.
Key Points
- • Karolinska CCC is the first center in Sweden to receive renewed accreditation until 2030.
- • Accreditation includes expanded pediatric cancer care services.
- • Focus on collaboration between clinical care and academic research in cancer.
- • Recognition signifies compliance with OECI quality criteria.
The Karolinska Comprehensive Cancer Center (Karolinska CCC) has made history by becoming the first center in Sweden to receive renewed accreditation, valid until 2030. This significant milestone reinforces its role in enhancing the integration of clinical care and research in the field of cancer treatment and care.
The renewed accreditation, recognized by the Organization of European Cancer Institutes (OECI), indicates that Karolinska CCC meets high-quality criteria. This achievement bolstered the collaborative efforts between Karolinska University Hospital and Karolinska Institutet (KI), paving the way for innovative cancer care and training, particularly with the inclusion of pediatric cancer care services. The expansion into pediatric oncology is particularly notable, as it facilitates a smoother transition for younger patients to adult care, addressing critical gaps in service continuity.
Elias Arnér, chair of Cancer Research KI, stated that the framework provided by Karolinska CCC significantly enhances the integration of clinical and academic cancer research activities. Eva Jolly, head of Karolinska CCC, highlighted the importance of this recognition, indicating it will enable the center to make further advancements in both research and treatment of cancer, emphasizing the commitment to comprehensive care for all age groups. The center's leadership in cancer treatment and research is expected to strengthen its status as a pivotal institution in the Stockholm region and beyond.